Patents
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
07/2009
07/10/2009CA2710230A1 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
07/09/2009WO2009083457A1 Novel functionalized (meth)acrylic monomers and polymers from acetylenic alcohols
07/09/2009US20090176837 Compounds with activity at retinoic acid receptors
07/08/2009EP1836173A4 Anti-inflammatory medicaments
07/08/2009CN101475538A Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
07/08/2009CN100509898C Method for dimerisation ispohorone diisolyanate
07/08/2009CN100509773C Alpha -amino-n-hydroxy-acetamide derivatives
07/07/2009US7557244 Substituted biphenyl carboxylic acids and derivatives thereof
07/07/2009CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
07/02/2009US20090171008 Novel functionalized (METH)acrylic monomers and polymers for acetylenic alcohols
07/02/2009US20090170883 3-arylphenyl sulfide derivative and insecticide and miticide
07/02/2009US20090170881 New inhibitors of histone deacetylase
07/02/2009US20090170874 Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists
07/02/2009US20090170836 New inhibitors of histone deacetylase
07/02/2009US20090170824 Diarylsulfones as 5-HT2A Antagonists
07/02/2009US20090170812 Transcription factor modulating compounds and methods of use thereof
07/01/2009EP1226127B1 Substituted phenyl sulfamoyl carboxamides
07/01/2009CN100506776C NK1 antagonists
06/2009
06/30/2009US7553972 Benzamide inhibitors of the P2X7 receptor
06/25/2009WO2009079593A1 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor
06/25/2009WO2009078587A2 Composition for prevention and treatment of cancer containing triazolyl-thio-ethanone derivatives inhibiting activity of protein phosphatases or pharmaceutically acceptable salts thereof as an active ingredient
06/25/2009WO2009078498A1 Biarylpyrazole 4-carboxamides as cannabinoid cb1 receptor ligands
06/25/2009WO2009078036A2 Process and intermediate of letrozole
06/25/2009WO2009077990A1 Aminotriazole derivatives as alx agonists
06/25/2009WO2009077366A1 Triazole-substituted arylamide derivatives and their use as p2x3 and /or p2x2/3 purinergic receptor antagonists
06/25/2009WO2009076747A1 Viral polymerase inhibitors
06/25/2009US20090162307 Photolatent Systems
06/25/2009US20090160324 Triazole Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device
06/25/2009CA2708324A1 Viral polymerase inhibitors
06/25/2009CA2707422A1 Triazole-substituted arylamide derivatives and their use as p2x3 and /or p2x2/3 purinergic receptor antagonists
06/25/2009CA2706839A1 Aminotriazole derivatives as alx agonists
06/24/2009CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase
06/23/2009US7550601 1-Amino-3-substituted-1,2,3-triazolium salts; quarternary salts are easily converted with appropriate silver salts to wide array of new quarternary salts with various anions, with many of these salts having melting points below 100 C, classifying them as ionic liquids; propellants, agriculture, medicine
06/23/2009US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
06/18/2009WO2009075890A2 Method for synthesis of triazole compounds that modulate hsp90 activity
06/18/2009WO2009075778A2 Nonpeptidic inhibitors of cruzain
06/18/2009WO2009075080A1 Fluoroalkylsulfide derivative and pest control agent
06/18/2009WO2009046841A3 Piperidine and piperazine derivatives for treating tumours
06/17/2009EP1611088B1 Hydroxamates as therapeutic agents
06/17/2009EP1542990B1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors
06/17/2009CN100502087C 场致发光器件 Electroluminescent device
06/16/2009US7547802 Compounds for the treatment of metabolic disorders
06/11/2009WO2009070873A1 Substituted 2-naphthoic acids as antagonists of gpr105 activity
06/11/2009WO2007083320A3 Conversion of aromatic diazonium salt to aryl hydrazine
06/11/2009US20090149444 Benzylamine analogues
06/11/2009CA2706632A1 Substituted 2-naphthoic acids as antagonists of gpr105 activity
06/10/2009EP2066646A1 Process for the preparation of pure anastrozole
06/10/2009EP2066632A1 Benzophenone derivatives useful for inhibiting formation of microtubule
06/10/2009CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase
06/10/2009CN101450932A Amide-containing triazoles compounds, preparation method, application thereof and composition containing the same
06/10/2009CN101450931A Tert-butyl-containing triazoles compounds, preparation method, application thereof and composition containing the same
06/10/2009CN100497319C Rectifying method for methyl benzotrizole
06/09/2009US7544738 Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)
06/04/2009WO2009070740A2 Novel compounds and compositions and methods of use
06/04/2009WO2009069312A1 Aryl (1h-1,2,4-triazol-1-yl) compound, and process for production thereof
06/04/2009WO2009069140A1 An improved process for preparation of letrozole and its intermediates
06/04/2009US20090143370 Non-nucleoside Reverse Transcriptase Inhibitors
06/04/2009US20090142347 Tissue-Nonspecific Alkaline Phosphatase (TNAP): a Therapeutic Target for Arterial Calcification
06/04/2009CA2706858A1 Imidazole and triazole derivatives and methods of use
06/03/2009EP2065370A1 2-cyanobenzene sulfonamides as pesticides
06/03/2009EP2065369A1 Urea compound or salt thereof
06/03/2009CN101448798A Compounds and methods for modulating FXR
06/03/2009CN101448797A Heterocyclic type cinnamide derivative
06/03/2009CN101445489A 1-azolyl-2-arylpropyl-2-ol, preparation method and application thereof
06/03/2009CN101445488A Triazoles compounds with antimicrobial activity and preparation method and pharmaceutical use thereof
06/03/2009CN101444496A Compounds for the treatment of metabolic disorders
06/02/2009US7541375 Azole derivatives and pharmaceutical compositions containing them
06/02/2009US7541374 Malononitrile compounds and use thereof
06/02/2009US7541369 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2009US7541096 Blue emitting, durable, organoelectrouminescent layers containing 2H-benzotriazole compounds; full color display panels; light emission efficiency and brightness
05/2009
05/28/2009WO2009067663A1 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
05/28/2009WO2009066060A2 4-substituted-6-isopropyl-benzene-1,3-diol compounds and their use
05/28/2009WO2009049180A3 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
05/28/2009US20090137585 N-acylsulfonamide apoptosis promoters
05/28/2009US20090137021 Anti-inflammatory medicaments
05/27/2009EP2061760A1 Benzo-fused compounds for use in treating metabolic disorders
05/27/2009EP0934287B1 Heterocyclic esters and amides
05/27/2009CN101443346A Hybrid compounds based on polyol(s) and at least one other molecular entity, polymer or otherwise, especially of the polyorganosiloxane type, method for the preparation thereof, and applications of th
05/27/2009CN101443003A Triazole derivatives II
05/27/2009CN101440068A Preparation of 4-(4-ethoxycarbonyl-1,2,3-triazole) phenylacetylene
05/27/2009CN100491356C Compounds exhibiting thrombopoietin receptor agaonism
05/27/2009CN100491319C Process for producing epoxytriazole compound and intermediate therefor
05/26/2009US7538230 Reacting 1,2,4 triazole with activated bis-(4-cyanophenyl)-methane to give letrazole, the activated bis-(4-cyanophenyl)-methane comprises a leaving groups like hydroxy halogens and sulfonates; The impurity isoletrozole is oxidized to 4,4'- dicyanobenzophenone, which then seperated by crystallization
05/26/2009US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4
05/26/2009CA2344058C Diaminopropionic acid derivatives
05/21/2009US20090131673 Electroluminescent Device
05/21/2009US20090131438 Triazole derivative
05/21/2009US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease
05/20/2009CN101434583A Phenyl bis (benzotriazol) dicarboxylate compound
05/20/2009CN101434582A Phenyl (benzotriazolyl) benzoate compound
05/19/2009US7534814 Mutilin derivatives and their use as antibacterials
05/19/2009CA2498047C Novel imidazole compounds as transforming growth factor (tgf) inhibitors
05/14/2009WO2009061652A1 Compounds which modulate the cb2 receptor
05/14/2009WO2009060053A1 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors
05/14/2009US20090124669 Structural Analogues of Avenanthramides, Their Use in Compositions Useful in the Treatment of Dermatological Disorders
05/14/2009US20090123372 radioactively labeled high affinity CA-IX ligands that identify enzymatic activity of cell-surface expressed carbonic anhydrase-IX (CA-IX), a protein over expressed in patients in with tumor growth; sulfonamide compounds useful for in vivo positron emission tomography for the diagnosis of cancer
05/14/2009CA2705113A1 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors
05/14/2009CA2704684A1 Compounds which modulate the cb2 receptor
05/13/2009EP1587795B1 N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as cgrp-antagonists for treating a headache
05/13/2009CN101429168A Method for preparation of bactericide of flutriafol
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 178